Document is current

Article History

Received: 22 January 2023

Accepted: 8 March 2023

First Online: 23 March 2023

Change Date: 5 October 2023

Change Type: Update

Change Details: The CRUI-CARE TA funding note has been removed

Declarations

:

: All subjects who present at our inpatient and outpatient service do sign a written informed consent (reviewed by our Ethical Committee: protocol number 71200206) to have their clinical data potentially used for teaching and research purposes (provided that these data are anonymously treated). The research was conducted in accordance with the Declaration of Helsinki in its most recent version (64thWMA General Assembly, Fortaleza, Brazil, October 2013).

: Not applicable.

: GDS has been a speaker for Lundbeck and Angelini. GM is/has been a consultant and/or a speaker and/or has received research grants from Angelini, Boheringer Ingelheim, FB—Health, Janssen, Lundbeck, Otsuka, Innova Pharma. UA is/has been a speaker and/or consultant and has received research grants from Angelini, Innova Pharma, Neuraxpharm, Janssen, Lundbeck, Boheringer Ingelheim. GR is/has been a speaker and/or consultant from Angelini, Janssen, Lundbeck, Otsuka, Viatris. GP declares that she has no competing interests.